Home›Immunology›Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
ImmunologyJoVE (Open Access)Citable · DOI
Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
DOI: 10.3791/2668-v
What you'll learn
✓Infect primary CD4+ T-cells with HIV-1
✓Purify infected cells via CD4 down-modulation
✓Measure NK degranulation by CD107a assay
✓Quantify NK cytotoxicity by 51Cr release
Protocol
Biopharma Insights Cytotoxicity assays to measure natural killer cell lytic responses to HIV-infected cells is limited by the purity of the target cells. We demonstrate here the isolation of a highly purified population of HIV-1 infected primary T-cell blasts by taking advantage of HIV-1 s ability to down-modulate CD4.
Difficulty
advanced
Total time
~2 weeks (culture and infection) plus 1 day for assays
Model organism
Human primary CD4+ T-cells and HIV-1
Biosafety
BSL-2
Steps
1
Infect CD4+ T-cells with HIV-1
Infect isolated primary CD4+ T-cell blasts with HIV-1 and culture to allow viral replication and CD4 down-modulation.
▶ 01:14
2
Purify HIV-1 infected cells
Exploit HIV-1-induced CD4 down-modulation to isolate a highly pure population of infected cells.
▶ 02:42
3
Perform CD107a degranulation assay
Co-culture NK cells with infected targets and measure CD107a surface expression as a degranulation marker.
▶ 03:41
4
Perform 51Cr release assay
Label target cells with 51Cr and quantify NK cell-mediated cytotoxicity by chromium release.
▶ 06:41
5
Evaluate degranulation and cytotoxicity
Analyze CD107a expression and 51Cr release data to assess NK cell lytic responses.
▶ 10:07
6
Review conclusions
Summarize the utility of purified HIV-1 infected primary T-cells as targets in NK cytotoxic assays.
▶ 11:45
💬 Comments coming soon
New protocols and pitfalls, in your inbox
A short email when we add notable lab videos and failure cases. No spam, unsubscribe anytime.